New cancer clinical trial: Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable NSCLC

Published on: January 28, 2019 at 12:00PM
Condition:   Non-Small Cell Lung Cancer
Interventions:   Drug: Durvalumab;   Radiation: Proton beam therapy RT
Sponsor:   Case Comprehensive Cancer Center
Not yet recruiting
http://bit.ly/2WtUJ6b